<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37569899</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>15</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>07</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Molecular Mechanisms of Endothelialitis in SARS-CoV-2 Infection: Evidence for VE-Cadherin Cleavage by ACE2.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">12525</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms241512525</ELocationID><Abstract><AbstractText>Long COVID-19 syndrome appears after Severe Acute Respiratory Syndrome-Corona Virus (SARS-CoV-2) infection with acute damage to microcapillaries, microthrombi, and endothelialitis. However, the mechanisms involved in these processes remain to be elucidated. All blood vessels are lined with a monolayer of endothelial cells called vascular endothelium, which provides a the major function is to prevent coagulation. A component of endothelial cell junctions is VE-cadherin, which is responsible for maintaining the integrity of the vessels through homophilic interactions of its Ca<sup>++</sup>-dependent adhesive extracellular domain. Here we provide the first evidence that VE-cadherin is a target in vitro for ACE2 cleavage because its extracellular domain (hrVE-ED) contains two amino acid sequences for ACE2 substrate recognition at the positions <sup>256</sup>P-F<sup>257</sup> and <sup>321</sup>PMKP-<sup>325</sup>L. Indeed, incubation of hrVE-ED with the active ectopeptidase hrACE2 for 16 hrs in the presence of 10 &#x3bc;M ZnCl<sub>2</sub> showed a dose-dependent (from 0.2 ng/&#x3bc;L to 2 ng/&#x3bc;L) decrease of the VE-cadherin immunoreactive band. In vivo, in the blood from patients having severe COVID-19 we detected a circulating form of ACE2 with an apparent molecular mass of 70 kDa, which was barely detectable in patients with mild COVID-19. Of importance, in the patients with severe COVID-19 disease, the presence of three soluble fragments of VE-cadherin (70, 62, 54 kDa) were detected using the antiEC1 antibody while only the 54 kDa fragment was present in patients with mild disease. Altogether, these data clearly support a role for ACE2 to cleave VE-cadherin, which leads to potential biomarkers of SARS-CoV-2 infection related with the vascular disease in "Long COVID-19".</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bouillet</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8245-4767</Identifier><AffiliationInfo><Affiliation>University Grenoble Alpes, CNRS, TIMC-IMAG/T-RAIG (UMR 5525), 38000 Grenoble, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grenoble Hospital Grenoble Alpes (CHUGA), University Grenoble Alpes, 38000 Grenoble, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine, University Hospital Centre Grenoble Alpes, CEDEX 9, 38043 Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deroux</LastName><ForeName>Alban</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9098-7368</Identifier><AffiliationInfo><Affiliation>Grenoble Hospital Grenoble Alpes (CHUGA), University Grenoble Alpes, 38000 Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benmarce</LastName><ForeName>Meryem</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Grenoble Alpes, CNRS, TIMC-IMAG/SyNaBi (UMR 5525), 38000 Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu&#xe9;rin</LastName><ForeName>Chlo&#xe9;</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Internal Medicine, University Hospital Centre Grenoble Alpes, CEDEX 9, 38043 Grenoble, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Grenoble Alpes, INSERM U13, CEA, Institute of Interdisciplinary Research of Grenoble (IRIG), Laboratory of Biosciences et Bioing&#xe9;nierie Pour la Sant&#xe9; (BGE)-Biomics, 38000 Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouvet</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University Grenoble Alpes, CNRS, TIMC-IMAG/T-RAIG (UMR 5525), 38000 Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garnier</LastName><ForeName>Olivia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>University Grenoble Alpes, INSERM U13, CEA, Institute of Interdisciplinary Research of Grenoble (IRIG), Laboratory of Biosciences et Bioing&#xe9;nierie Pour la Sant&#xe9; (BGE)-Biomics, 38000 Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Donald K</ForeName><Initials>DK</Initials><Identifier Source="ORCID">0000-0001-5913-2372</Identifier><AffiliationInfo><Affiliation>University Grenoble Alpes, CNRS, TIMC-IMAG/SyNaBi (UMR 5525), 38000 Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vilgrain</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-5511-5871</Identifier><AffiliationInfo><Affiliation>University Grenoble Alpes, INSERM U13, CEA, Institute of Interdisciplinary Research of Grenoble (IRIG), Laboratory of Biosciences et Bioing&#xe9;nierie Pour la Sant&#xe9; (BGE)-Biomics, 38000 Grenoble, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C094954">cadherin 5</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015820">Cadherins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="Y">Endothelial Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015820" MajorTopicYN="N">Cadherins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004730" MajorTopicYN="N">Endothelium, Vascular</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">VE-cadherin</Keyword><Keyword MajorTopicYN="N">endothelium</Keyword><Keyword MajorTopicYN="N">long COVID syndrome</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>12</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>12</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37569899</ArticleId><ArticleId IdType="pmc">PMC10419376</ArticleId><ArticleId IdType="doi">10.3390/ijms241512525</ArticleId><ArticleId IdType="pii">ijms241512525</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zanini G., Selleri V., Roncati L., Coppi F., Nasi M., Farinetti A., Manenti A., Pinti M., Mattioli A.V. Vascular &#x201c;Long COVID&#x201d;: A new vessel disease? Angiology. 2023:33197231153204. doi: 10.1177/00033197231153204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00033197231153204</ArticleId><ArticleId IdType="pmc">PMC9895315</ArticleId><ArticleId IdType="pubmed">36652923</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S., Huang H., Zhang L., Zhou X., Du C., et al. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. 2020;180:934&#x2013;943. doi: 10.1001/jamainternmed.2020.0994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.0994</ArticleId><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 1 January 2020)].  Available online:  https://covid19.who.int.</Citation></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., Mehra M.R., Schuepbach R.A., Ruschitzka F., Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N. Engl. J. Med. 2020;383:120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhetri S., Khamis F., Pandak N., Al Khalili H., Said E., Petersen E. A fatal case of COVID-19 due to metabolic acidosis following dysregulate inflammatory response (cytokine storm) IDCases. 2020;21:e00829. doi: 10.1016/j.idcr.2020.e00829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idcr.2020.e00829</ArticleId><ArticleId IdType="pmc">PMC7236721</ArticleId><ArticleId IdType="pubmed">32483525</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampugnani M.G., Dejana E., Giampietro C. Vascular Endothelial (VE)-Cadherin, endothelial adherens junctions, and vascular disease. Cold Spring Harb. Perspect. Biol. 2018;10:a029322. doi: 10.1101/cshperspect.a029322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a029322</ArticleId><ArticleId IdType="pmc">PMC6169812</ArticleId><ArticleId IdType="pubmed">28851747</ArticleId></ArticleIdList></Reference><Reference><Citation>Gory-Faur&#xe9; S., Prandini M.H., Pointu H., Roullot V., Pignot-Paintrand I., Vernet M., Huber P. Role of vascular endothelial-cadherin in vascular morphogenesis. Development. 1999;126:2093&#x2013;2102. doi: 10.1242/dev.126.10.2093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.126.10.2093</ArticleId><ArticleId IdType="pubmed">10207135</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidib&#xe9; A., Mannic T., Arboleas M., Subileau M., Gulino-Debrac D., Bouillet L., Jan M., Vandhuick T., Le Lo&#xeb;t X., Vittecoq O., et al. Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: Evidence for tumor necrosis factor &#x3b1;-induced VE-cadherin cleavage. Arthritis Rheum. 2012;64:77&#x2013;87. doi: 10.1002/art.33336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.33336</ArticleId><ArticleId IdType="pubmed">21905018</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudry-Clergeon H., Stengel D., Ninio E., Vilgrain I. Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3&#x2032;-kinase. FASEB J. 2005;19:512&#x2013;520. doi: 10.1096/fj.04-2202com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.04-2202com</ArticleId><ArticleId IdType="pmc">PMC4848345</ArticleId><ArticleId IdType="pubmed">15791001</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallez Y., Vilgrain I., Huber P. Angiogenesis: The VE-cadherin switch. Trends Cardiovasc. Med. 2006;16:55&#x2013;59. doi: 10.1016/j.tcm.2005.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2005.11.008</ArticleId><ArticleId IdType="pubmed">16473763</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambeng N., Wallez Y., Rampon C., Cand F., Christ&#xe9; G., Gulino-Debrac D., Vilgrain I., Huber P. Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues. Circ. Res. 2005;96:384&#x2013;391. doi: 10.1161/01.RES.0000156652.99586.9f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000156652.99586.9f</ArticleId><ArticleId IdType="pmc">PMC2798002</ArticleId><ArticleId IdType="pubmed">15662029</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilgrain I., Sidib&#xe9; A., Polena H., Cand F., Mannic T., Arboleas M., Boccard S., Baudet A., Gulino-Debrac D., Bouillet L., et al. Evidence for post-translational processing of vascular endothelial (VE)-cadherin in brain tumors: Towards a candidate biomarker. PLoS ONE. 2013;8:e80056. doi: 10.1371/journal.pone.0080056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0080056</ArticleId><ArticleId IdType="pmc">PMC3864785</ArticleId><ArticleId IdType="pubmed">24358106</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouillet L., Mannic T., Arboleas M., Subileau M., Massot C., Drouet C., Huber P., Vilgrain I. Hereditary angioedema: Key role for kallikrein and bradykinin in vascular endothelial-cadherin cleavage and edema formation. J. Allergy Clin. Immunol. 2011;128:232&#x2013;234. doi: 10.1016/j.jaci.2011.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2011.02.017</ArticleId><ArticleId IdType="pubmed">21439626</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouillet L., Vilgrain I. VE-cadherin, a potential marker for endothelial cell activation during hereditary angioedema attacks. J. Allergy Clin. Immunol. 2014;134:241. doi: 10.1016/j.jaci.2014.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2014.04.016</ArticleId><ArticleId IdType="pubmed">24875615</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033&#x2013;1034. doi: 10.1016/S0140-6736(20)30628-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R., Perlman S. Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology. Semin. Immunopathol. 2017;39:529&#x2013;539. doi: 10.1007/s00281-017-0629-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0629-x</ArticleId><ArticleId IdType="pmc">PMC7079893</ArticleId><ArticleId IdType="pubmed">28466096</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyerstedt S., Casaro E.B., Rangel &#xc9;.B. COVID-19: Angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur. J. Clin. Microbiol. Infect. Dis. 2021;40:905&#x2013;919. doi: 10.1007/s10096-020-04138-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04138-6</ArticleId><ArticleId IdType="pmc">PMC7778857</ArticleId><ArticleId IdType="pubmed">33389262</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., Huan Y., Yang P., Zhang Y., Deng W., et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 2005;11:875&#x2013;879. doi: 10.1038/nm1267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1267</ArticleId><ArticleId IdType="pmc">PMC7095783</ArticleId><ArticleId IdType="pubmed">16007097</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004;203:631&#x2013;637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Vickers C., Hales P., Kaushik V., Dick L., Gavin J., Tang J., Godbout K., Parsons T., Baronas E., Hsieh F., et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem. 2002;277:14838&#x2013;14843. doi: 10.1074/jbc.M200581200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M200581200</ArticleId><ArticleId IdType="pubmed">11815627</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama I.E., Ravera A., Santema B.T., van Goor H., Ter Maaten J.M., Cleland J.G.F., Rienstra M., Friedrich A.W., Samani N.J., Ng L.L., et al. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur. Heart J. 2020;41:181017. doi: 10.1093/eurheartj/ehaa373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa373</ArticleId><ArticleId IdType="pmc">PMC7239195</ArticleId><ArticleId IdType="pubmed">32388565</ArticleId></ArticleIdList></Reference><Reference><Citation>Kragstrup T.W., Singh H.S., Grundberg I., Nielsen A.L., Rivellese F., Mehta A., Goldberg M.B., Filbin M.R., Qvist P., Bibby B.M. Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients. PLoS ONE. 2021;16:e0252799. doi: 10.1371/journal.pone.0252799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0252799</ArticleId><ArticleId IdType="pmc">PMC8177449</ArticleId><ArticleId IdType="pubmed">34086837</ArticleId></ArticleIdList></Reference><Reference><Citation>Brasch J., Harrison O.J., Ahlsen G., Carnally S.M., Henderson R.M., Honig B., Shapiro L. Structure and binding mechanism of vascular endothelial cadherin: A divergent classical cadherin. J. Mol. Biol. 2011;408:57&#x2013;73. doi: 10.1016/j.jmb.2011.01.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2011.01.031</ArticleId><ArticleId IdType="pmc">PMC3084036</ArticleId><ArticleId IdType="pubmed">21269602</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobe N., Di Fulvio M., Kashkari N., Chodavarapu H., Somineni H.K., Singh R., Elased K.M. Functional and molecular evidence for expression of the renin angiotensin system and ADAM17-mediated ACE2 shedding in COS7 cells. Am. J. Physiol. Cell Physiol. 2015;308:C767&#x2013;C777. doi: 10.1152/ajpcell.00247.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00247.2014</ArticleId><ArticleId IdType="pmc">PMC4420792</ArticleId><ArticleId IdType="pubmed">25740155</ArticleId></ArticleIdList></Reference><Reference><Citation>Tompa P. The principle of conformational signaling. Chem. Soc. Rev. 2016;45:4252&#x2013;4284. doi: 10.1039/C6CS00011H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C6CS00011H</ArticleId><ArticleId IdType="pubmed">27242242</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornilov S.A., Lucas I., Jade K., Dai C.L., Lovejoy J.C., Magis A.T. Plasma levels of soluble ACE2are associated with sex, Metabolic Syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in COVID-19. Crit. Care. 2020;24:452. doi: 10.1186/s13054-020-03141-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03141-9</ArticleId><ArticleId IdType="pmc">PMC7373836</ArticleId><ArticleId IdType="pubmed">32698840</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner F.J., Smith A.I., Hooper N.M., Turner A.J. Angiotensin-converting enzyme-2: A molecular and cellular perspective. Cell. Mol. Life Sci. 2004;61:2704&#x2013;2713. doi: 10.1007/s00018-004-4240-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-004-4240-7</ArticleId><ArticleId IdType="pmc">PMC7079784</ArticleId><ArticleId IdType="pubmed">15549171</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliou A.G., Keskinidou C., Jahaj E., Gallos P., Dimopoulou I., Kotanidou A., Orfanos S.E. ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients. Cells. 2021;10:186. doi: 10.3390/cells10010186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10010186</ArticleId><ArticleId IdType="pmc">PMC7832393</ArticleId><ArticleId IdType="pubmed">33477776</ArticleId></ArticleIdList></Reference><Reference><Citation>Montanari M., Canonico B., Nordi E., Vandini D., Barocci S., Benedetti S., Carlotti E., Zamai L. Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19? Adv. Biol. Regul. 2021;81:100820. doi: 10.1016/j.jbior.2021.100820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbior.2021.100820</ArticleId><ArticleId IdType="pmc">PMC8359569</ArticleId><ArticleId IdType="pubmed">34419773</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amato M., Vertui V., Pandolfi L., Bozzini S., Fossali T., Colombo R., Aliberti A., Fumagalli M., Iadarola P., Did&#xf2; C., et al. Investigating the link between Alpha-1 Antitrypsin and human neutrophil elastase in bronchoalveolar lavage fluid of COVID-19 patients. Curr. Issues Mol. Biol. 2022;44:2122&#x2013;2138. doi: 10.3390/cimb44050143.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cimb44050143</ArticleId><ArticleId IdType="pmc">PMC9164061</ArticleId><ArticleId IdType="pubmed">35678672</ArticleId></ArticleIdList></Reference><Reference><Citation>Flemming S., Burkard N., Renschler M., Vielmuth F., Meir M., Schick M.A., Wunder C., Germer C.T., Spindler V., Waschke J., et al. Soluble VE-cadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis. Cardiovasc. Res. 2015;107:32&#x2013;44. doi: 10.1093/cvr/cvv144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvv144</ArticleId><ArticleId IdType="pubmed">25975259</ArticleId></ArticleIdList></Reference><Reference><Citation>Harki O., Tamisier R., P&#xe9;pin J.L., Bailly S., Mahmani A., Gonthier B., Salomon A., Vilgrain I., Faury G., Brian&#xe7;on-Marjollet A. VE-cadherin cleavage in sleep apnea: New insights into intermittent hypoxia-related endothelial permeability. Eur. Respir. J. 2021;58:2004518. doi: 10.1183/13993003.04518-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.04518-2020</ArticleId><ArticleId IdType="pubmed">33737411</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaise S., Polena H., Vilgrain I. Soluble vascular endothelial-cadherin and auto-antibodies to human vascular endothelial-cadherin in human diseases: Two new biomarkers of endothelial dysfunction. Vasc. Med. 2015;20:557&#x2013;565. doi: 10.1177/1358863X15591201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1358863X15591201</ArticleId><ArticleId IdType="pubmed">26129735</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper N.M. Angiotensin converting enzyme: Implications from molecular biology for its physiological functions. Int. J. Biochem. 1991;23:641&#x2013;647. doi: 10.1016/0020-711X(91)90032-I.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0020-711X(91)90032-I</ArticleId><ArticleId IdType="pubmed">1650717</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel V.B., Clarke N., Wang Z., Fan D., Parajuli N., Basu R., Putko B., Kassiri Z., Turner A.J., Oudit G.Y. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: A positive feedback mechanism in the RAS. J. Mol. Cell Cardiol. 2014;66:167&#x2013;176. doi: 10.1016/j.yjmcc.2013.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2013.11.017</ArticleId><ArticleId IdType="pubmed">24332999</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia H.P., Look D.C., Tan P., Shi L., Hickey M., Gakhar L., Chappell M.C., Wohlford-Lenane C., McCray P.B., Jr. Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. Am. J. Physiol. Lung Cell Mol. Physiol. 2009;297:L84&#x2013;L96. doi: 10.1152/ajplung.00071.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00071.2009</ArticleId><ArticleId IdType="pmc">PMC2711803</ArticleId><ArticleId IdType="pubmed">19411314</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramchand J., Burrell L.M. Circulating ACE2: A novel biomarker of cardiovascular risk. Lancet. 2020;396:937&#x2013;939. doi: 10.1016/S0140-6736(20)32011-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32011-0</ArticleId><ArticleId IdType="pmc">PMC7529379</ArticleId><ArticleId IdType="pubmed">33010824</ArticleId></ArticleIdList></Reference><Reference><Citation>Scialo F., Daniele A., Amato F., Pastore L., Matera M.G., Cazzola M., Castaldo G., Bianco A. ACE2: The Major Cell Entry Receptor for SARS-CoV-2. Lung. 2020;198:867&#x2013;877. doi: 10.1007/s00408-020-00408-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-020-00408-4</ArticleId><ArticleId IdType="pmc">PMC7653219</ArticleId><ArticleId IdType="pubmed">33170317</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteil V., Kwon H., Prado P., Hagelkr&#xfc;ys A., Wimmer R.A., Stahl M., Leopoldi A., Garreta E., Hurtado Del Pozo C., Prosper F., et al. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. Cell. 2020;181:905&#x2013;913. doi: 10.1016/j.cell.2020.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.004</ArticleId><ArticleId IdType="pmc">PMC7181998</ArticleId><ArticleId IdType="pubmed">32333836</ArticleId></ArticleIdList></Reference><Reference><Citation>Allison S. Soluble ACE2 in SARS-CoV-2 infection. Nat. Rev. Nephrol. 2021;17:297. doi: 10.1038/s41581-021-00422-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00422-6</ArticleId><ArticleId IdType="pmc">PMC7985737</ArticleId><ArticleId IdType="pubmed">33758362</ArticleId></ArticleIdList></Reference><Reference><Citation>Epelman S., Tang W.H., Chen S.Y., Van Lente F., Francis G.S., Sen S. Detection of soluble angiotensin-converting enzyme 2 in heart failure: Insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system. J. Am. Coll. Cardiol. 2008;52:750&#x2013;754. doi: 10.1016/j.jacc.2008.02.088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2008.02.088</ArticleId><ArticleId IdType="pmc">PMC2856943</ArticleId><ArticleId IdType="pubmed">18718423</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilgrain I., Cand F., Pelletier L. Circulating VE-Cadherin as a Predictive Marker of Sensitivity or Resistance to Anti-Tumoral Treatment and Improved Method for the Detection of soluble Proteins. 20100121171A10. U.S. Patent. 2006 November 23;</Citation></Reference><Reference><Citation>Lambert D.W., Yarski M., Warner F.J., Thornhill P., Parkin E.T., Smith A.I., Hooper N.M., Turner A.J. Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2) J. Biol. Chem. 2005;280:30113&#x2013;30119. doi: 10.1074/jbc.M505111200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M505111200</ArticleId><ArticleId IdType="pmc">PMC8062222</ArticleId><ArticleId IdType="pubmed">15983030</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>